English

COLLAGENEX PHARMACEUTICALS INC

EDGAR

Annual report amendment (10-K/A) · filed 2008-04-10

51 filing records in this dataset, filed from 1996-07-31 to 2008-04-10. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

15.9 million USD

2007-09-30 · USD

Exact inputs and evidence

Revenue: 15933000 USD Source

Operating margin

-11.41%

2007-09-30 · %

Exact inputs and evidence

Operating Income: -1818000 USD Source
Revenue: 15933000 USD Source

Operating cash flow

-585 thousand USD

2007-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -6422000 USD Source
Operating Cash Flow: -5837000 USD Source

Free cash flow

-639 thousand USD

2007-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -6422000 USD Source
Operating Cash Flow: -5837000 USD Source
Capital Expenditure: 740000 USD Source
Capital Expenditure: 686000 USD Source

Cash and cash equivalents: 31.3 million USD 2007-09-30 Source
Exact value

31344000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2008-04-10.

Financial data available through: 2003-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2003-12-31
Operating income: 10 of 11 periods available· newest 2003-12-31
Net income: 10 of 11 periods available· newest 2003-12-31
Operating cash flow: 10 of 11 periods available· newest 2003-12-31
Capital expenditure: 10 of 11 periods available· newest 2003-12-31
Total assets: 9 of 11 periods available· newest 2003-12-31
liabilities: No compatible figures in this window
Current assets: 9 of 11 periods available· newest 2003-12-31
Current liabilities: 9 of 11 periods available· newest 2003-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2003-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+18.5%

Prior period

USD 44.62 million

2002-01-01 – 2002-12-31
Current period

USD 52.86 million

2003-01-01 – 2003-12-31

Exact inputs and evidence

52859000 − 44619000 = 8240000 USD

44619000 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
52859000 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · COLLAGENEX PHARMACEUTICALS INC · 2003-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Year-over-year change in Revenue: 8240000 USD Concept: fundies:Revenue Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 52859000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4178 Input fundies:Revenue: 44619000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4178
The citation records this snapshot. The page link may show a newer release later.
Net income
+612.5%

Prior period

USD 902,000

2002-01-01 – 2002-12-31
Current period

USD 6.43 million

2003-01-01 – 2003-12-31

Exact inputs and evidence

6427000 − 902000 = 5525000 USD

902000 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
6427000 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · COLLAGENEX PHARMACEUTICALS INC · 2003-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Year-over-year change in Net income: 5525000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 6427000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4348 Input fundies:NetIncome: 902000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4348
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+22.4%

Prior period

USD 3.95 million

2002-01-01 – 2002-12-31
Current period

USD 4.84 million

2003-01-01 – 2003-12-31

Exact inputs and evidence

4837000 − 3951000 = 886000 USD

3951000 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
4837000 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · COLLAGENEX PHARMACEUTICALS INC · 2003-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Year-over-year change in Operating cash flow: 886000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 4837000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4362 Input fundies:OperatingCashFlow: 3951000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4362
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+2.3%

Prior period

USD 298,000

2002-01-01 – 2002-12-31
Current period

USD 305,000

2003-01-01 – 2003-12-31

Exact inputs and evidence

305000 − 298000 = 7000 USD

298000 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
305000 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · COLLAGENEX PHARMACEUTICALS INC · 2003-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Year-over-year change in Capital expenditure: 7000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 305000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4365 Input fundies:CapitalExpenditure: 298000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4365
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2003 2003-01-01 – 2003-12-31

Revenue USD 52.86 million 100% of revenue
Operating costs Derived USD 46.49 million 88% of revenue
Operating income USD 6.37 million 12% of revenue
Tax, interest and other Derived −USD 60,000 −0.1% of revenue
Net income USD 6.43 million 12% of revenue

Cash

Operating cash flow USD 4.84 million 9.2% of revenue
Capital expenditure USD 305,000 0.6% of revenue
Free cash flow Derived USD 4.53 million 8.6% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1995 Not shown: operating income or net income is not reported.
1996 Operating loss: operating costs were 1,741% of revenue.
1997 Operating loss: operating costs were 3,083% of revenue.
1998 Operating loss: operating costs were 463% of revenue.
1999 Operating loss: operating costs were 195% of revenue.
2000 Operating loss: operating costs were 136% of revenue.
2001 Operating loss: operating costs were 124% of revenue.
2002 Net income was higher than operating income, so the split is not drawn.
2003 Net income was higher than operating income, so the split is not drawn.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1995 1995-01-01 – 1995-12-31	0	5183371 Derived	-5183371	85191 Derived	-5268562	-5333445 Derived	Source 1995-01-01 – 1995-12-31: 0 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -5183371 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -5268562 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -5321687 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 11758 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	400000	6963000 Derived	-6563000	-645000 Derived	-5918000	-5624000 Derived	Source 1996-01-01 – 1996-12-31: 400000 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -6563000 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -5918000 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -5567000 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 57000 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	334000	10296000 Derived	-9962000	-1338000 Derived	-8624000	-7059000 Derived	Source 1997-01-01 – 1997-12-31: 334000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -9962000 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -8624000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -6981000 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 78000 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	3461000	16015000 Derived	-12554000	-988000 Derived	-11566000	-12541000 Derived	Source 1998-01-01 – 1998-12-31: 3461000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -12554000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -11566000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -12311000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 230000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	16081000	31324000 Derived	-15243000	-652000 Derived	-14591000	-14558000 Derived	Source 1999-01-01 – 1999-12-31: 16081000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -15243000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -14591000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -13965000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 593000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	24271000	32944000 Derived	-8673000	157000 Derived	-8830000	-8934000 Derived	Source 2000-01-01 – 2000-12-31: 24271000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -8673000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -8830000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -8765000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 169000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	35232000	43599000 Derived	-8367000	-223000 Derived	-8144000	-8014000 Derived	Source 2001-01-01 – 2001-12-31: 35232000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -8367000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -8144000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -7883000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 131000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	44619000	43806000 Derived	813000	-89000 Derived	902000	3653000 Derived	Source 2002-01-01 – 2002-12-31: 44619000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: 813000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: 902000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: 3951000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 298000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	52859000	46492000 Derived	6367000	-60000 Derived	6427000	4532000 Derived	Source 2003-01-01 – 2003-12-31: 52859000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: 6367000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: 6427000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: 4837000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 305000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 52.9M 2003

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Revenue	0	Revenue: 0 Open source
19961996-12-31	Revenue	400000	Revenue: 400000 Open source
19971997-12-31	Revenue	334000	Revenue: 334000 Open source
19981998-12-31	Revenue	3461000	Revenue: 3461000 Open source
19991999-12-31	Revenue	16081000	Revenue: 16081000 Open source
20002000-12-31	Revenue	24271000	Revenue: 24271000 Open source
20012001-12-31	Revenue	35232000	Revenue: 35232000 Open source
20022002-12-31	Revenue	44619000	Revenue: 44619000 Open source
20032003-12-31	Revenue	52859000	Revenue: 52859000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

18.5% 2003

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
19961996-12-31	Year over year	No prior comparable period	Revenue: 400000 Open source Revenue: 0 Open source
19971997-12-31	Year over year	-16.5%	Revenue: 334000 Open source Revenue: 400000 Open source
19981998-12-31	Year over year	936.2%	Revenue: 3461000 Open source Revenue: 334000 Open source
19991999-12-31	Year over year	364.6%	Revenue: 16081000 Open source Revenue: 3461000 Open source
20002000-12-31	Year over year	50.9%	Revenue: 24271000 Open source Revenue: 16081000 Open source
20012001-12-31	Year over year	45.2%	Revenue: 35232000 Open source Revenue: 24271000 Open source
20022002-12-31	Year over year	26.6%	Revenue: 44619000 Open source Revenue: 35232000 Open source
20032003-12-31	Year over year	18.5%	Revenue: 52859000 Open source Revenue: 44619000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 12% 2003

Net margin 12.2% 2003

Free cash flow margin 8.6% 2003

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Operating margin	Not reported	Operating Income: -5183371 Open source Revenue: 0 Open source
19961996-12-31	Operating margin	-1,640.8%	Operating Income: -6563000 Open source Revenue: 400000 Open source
19971997-12-31	Operating margin	-2,982.6%	Operating Income: -9962000 Open source Revenue: 334000 Open source
19981998-12-31	Operating margin	-362.7%	Operating Income: -12554000 Open source Revenue: 3461000 Open source
19991999-12-31	Operating margin	-94.8%	Operating Income: -15243000 Open source Revenue: 16081000 Open source
20002000-12-31	Operating margin	-35.7%	Operating Income: -8673000 Open source Revenue: 24271000 Open source
20012001-12-31	Operating margin	-23.7%	Operating Income: -8367000 Open source Revenue: 35232000 Open source
20022002-12-31	Operating margin	1.8%	Operating Income: 813000 Open source Revenue: 44619000 Open source
20032003-12-31	Operating margin	12%	Operating Income: 6367000 Open source Revenue: 52859000 Open source
19951995-12-31	Net margin	Not reported	Net Income: -5268562 Open source Revenue: 0 Open source
19961996-12-31	Net margin	-1,479.5%	Net Income: -5918000 Open source Revenue: 400000 Open source
19971997-12-31	Net margin	-2,582%	Net Income: -8624000 Open source Revenue: 334000 Open source
19981998-12-31	Net margin	-334.2%	Net Income: -11566000 Open source Revenue: 3461000 Open source
19991999-12-31	Net margin	-90.7%	Net Income: -14591000 Open source Revenue: 16081000 Open source
20002000-12-31	Net margin	-36.4%	Net Income: -8830000 Open source Revenue: 24271000 Open source
20012001-12-31	Net margin	-23.1%	Net Income: -8144000 Open source Revenue: 35232000 Open source
20022002-12-31	Net margin	2%	Net Income: 902000 Open source Revenue: 44619000 Open source
20032003-12-31	Net margin	12.2%	Net Income: 6427000 Open source Revenue: 52859000 Open source
19951995-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -5321687 Open source Capital Expenditure: 11758 Open source
19961996-12-31	Free cash flow margin	-1,406%	Revenue: 400000 Open source Operating Cash Flow: -5567000 Open source Capital Expenditure: 57000 Open source
19971997-12-31	Free cash flow margin	-2,113.5%	Revenue: 334000 Open source Operating Cash Flow: -6981000 Open source Capital Expenditure: 78000 Open source
19981998-12-31	Free cash flow margin	-362.4%	Revenue: 3461000 Open source Operating Cash Flow: -12311000 Open source Capital Expenditure: 230000 Open source
19991999-12-31	Free cash flow margin	-90.5%	Revenue: 16081000 Open source Operating Cash Flow: -13965000 Open source Capital Expenditure: 593000 Open source
20002000-12-31	Free cash flow margin	-36.8%	Revenue: 24271000 Open source Operating Cash Flow: -8765000 Open source Capital Expenditure: 169000 Open source
20012001-12-31	Free cash flow margin	-22.7%	Revenue: 35232000 Open source Operating Cash Flow: -7883000 Open source Capital Expenditure: 131000 Open source
20022002-12-31	Free cash flow margin	8.2%	Revenue: 44619000 Open source Operating Cash Flow: 3951000 Open source Capital Expenditure: 298000 Open source
20032003-12-31	Free cash flow margin	8.6%	Revenue: 52859000 Open source Operating Cash Flow: 4837000 Open source Capital Expenditure: 305000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 4.8M 2003

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Operating cash flow	-5321687	Operating Cash Flow: -5321687 Open source
19961996-12-31	Operating cash flow	-5567000	Operating Cash Flow: -5567000 Open source
19971997-12-31	Operating cash flow	-6981000	Operating Cash Flow: -6981000 Open source
19981998-12-31	Operating cash flow	-12311000	Operating Cash Flow: -12311000 Open source
19991999-12-31	Operating cash flow	-13965000	Operating Cash Flow: -13965000 Open source
20002000-12-31	Operating cash flow	-8765000	Operating Cash Flow: -8765000 Open source
20012001-12-31	Operating cash flow	-7883000	Operating Cash Flow: -7883000 Open source
20022002-12-31	Operating cash flow	3951000	Operating Cash Flow: 3951000 Open source
20032003-12-31	Operating cash flow	4837000	Operating Cash Flow: 4837000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 4.5M 2003

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Free cash flow	-5333445	Operating Cash Flow: -5321687 Open source Capital Expenditure: 11758 Open source
19961996-12-31	Free cash flow	-5624000	Operating Cash Flow: -5567000 Open source Capital Expenditure: 57000 Open source
19971997-12-31	Free cash flow	-7059000	Operating Cash Flow: -6981000 Open source Capital Expenditure: 78000 Open source
19981998-12-31	Free cash flow	-12541000	Operating Cash Flow: -12311000 Open source Capital Expenditure: 230000 Open source
19991999-12-31	Free cash flow	-14558000	Operating Cash Flow: -13965000 Open source Capital Expenditure: 593000 Open source
20002000-12-31	Free cash flow	-8934000	Operating Cash Flow: -8765000 Open source Capital Expenditure: 169000 Open source
20012001-12-31	Free cash flow	-8014000	Operating Cash Flow: -7883000 Open source Capital Expenditure: 131000 Open source
20022002-12-31	Free cash flow	3653000	Operating Cash Flow: 3951000 Open source Capital Expenditure: 298000 Open source
20032003-12-31	Free cash flow	4532000	Operating Cash Flow: 4837000 Open source Capital Expenditure: 305000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1995-12-31	Liabilities / assets	Not reported	Total Assets: 5839985 Open source
1996-12-31	Liabilities / assets	Not reported	Total Assets: 18436544 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 23165000 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 14740000 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 18563000 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 10431000 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 14698000 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 17634000 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 44132000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.25× 2003

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Current assets / current liabilities	11.34×	Current Assets: 5813717 Open source Current Liabilities: 512527 Open source
19961996-12-31	Current assets / current liabilities	21.75×	Current Assets: 18368890 Open source Current Liabilities: 844359 Open source
19971997-12-31	Current assets / current liabilities	9.38×	Current Assets: 23049000 Open source Current Liabilities: 2457000 Open source
19981998-12-31	Current assets / current liabilities	2.65×	Current Assets: 14460000 Open source Current Liabilities: 5459000 Open source
19991999-12-31	Current assets / current liabilities	3.68×	Current Assets: 17827000 Open source Current Liabilities: 4840000 Open source
20002000-12-31	Current assets / current liabilities	2.19×	Current Assets: 9752000 Open source Current Liabilities: 4444000 Open source
20012001-12-31	Current assets / current liabilities	1.9×	Current Assets: 13251000 Open source Current Liabilities: 6957000 Open source
20022002-12-31	Current assets / current liabilities	1.69×	Current Assets: 14713000 Open source Current Liabilities: 8721000 Open source
20032003-12-31	Current assets / current liabilities	4.25×	Current Assets: 41860000 Open source Current Liabilities: 9850000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	−USD 2.65 million Exact value Exact value: -2653465 USD 1994-01-01 – 1994-12-31: -2653465 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLLAGENEX PHARMACEUTICALS INC · 1994-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Net Income: -2653465 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2653465 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000893220-97-000631.txt#2058 The citation records this snapshot. The page link may show a newer release later.	−USD 2.8 million Exact value Exact value: -2803847 USD 1994-01-01 – 1994-12-31: -2803847 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLLAGENEX PHARMACEUTICALS INC · 1994-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Operating Cash Flow: -2803847 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2803847 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000893220-97-000631.txt#2073 The citation records this snapshot. The page link may show a newer release later.	USD 5,834 Exact value Exact value: 5834 USD 1994-01-01 – 1994-12-31: 5834 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLLAGENEX PHARMACEUTICALS INC · 1994-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Capital Expenditure: 5834 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5834 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000893220-97-000631.txt#2076 The citation records this snapshot. The page link may show a newer release later.	−USD 2.81 million Calculation and evidence -2803847 − 5834 USD Exact free cash flow: -2809681 USD 1994-01-01 – 1994-12-31: -2803847 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 5834 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLLAGENEX PHARMACEUTICALS INC · 1994-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Free cash flow: -2809681 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2803847 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000893220-97-000631.txt#2073 Input fundies:CapitalExpenditure: 5834 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000893220-97-000631.txt#2076 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	−USD 5.27 million Exact value Exact value: -5268562 USD 1995-01-01 – 1995-12-31: -5268562 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLLAGENEX PHARMACEUTICALS INC · 1995-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Net Income: -5268562 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5268562 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0001015357-98-000027.txt#2069 The citation records this snapshot. The page link may show a newer release later.	−USD 5.32 million Exact value Exact value: -5321687 USD 1995-01-01 – 1995-12-31: -5321687 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLLAGENEX PHARMACEUTICALS INC · 1995-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Operating Cash Flow: -5321687 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5321687 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000893220-97-000631.txt#2073 The citation records this snapshot. The page link may show a newer release later.	USD 11,758 Exact value Exact value: 11758 USD 1995-01-01 – 1995-12-31: 11758 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLLAGENEX PHARMACEUTICALS INC · 1995-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Capital Expenditure: 11758 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11758 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000893220-97-000631.txt#2076 The citation records this snapshot. The page link may show a newer release later.	−USD 5.33 million Calculation and evidence -5321687 − 11758 USD Exact free cash flow: -5333445 USD 1995-01-01 – 1995-12-31: -5321687 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 11758 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLLAGENEX PHARMACEUTICALS INC · 1995-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Free cash flow: -5333445 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5321687 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000893220-97-000631.txt#2073 Input fundies:CapitalExpenditure: 11758 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000893220-97-000631.txt#2076 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 5.92 million Exact value Exact value: -5918000 USD 1996-01-01 – 1996-12-31: -5918000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLLAGENEX PHARMACEUTICALS INC · 1996-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Net Income: -5918000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5918000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0001015357-99-000043.txt#2318 The citation records this snapshot. The page link may show a newer release later.	−USD 5.57 million Exact value Exact value: -5567000 USD 1996-01-01 – 1996-12-31: -5567000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLLAGENEX PHARMACEUTICALS INC · 1996-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Operating Cash Flow: -5567000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5567000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0001015357-99-000043.txt#2333 The citation records this snapshot. The page link may show a newer release later.	USD 57,000 Exact value Exact value: 57000 USD 1996-01-01 – 1996-12-31: 57000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLLAGENEX PHARMACEUTICALS INC · 1996-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Capital Expenditure: 57000 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 57000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0001015357-99-000043.txt#2337 The citation records this snapshot. The page link may show a newer release later.	−USD 5.62 million Calculation and evidence -5567000 − 57000 USD Exact free cash flow: -5624000 USD 1996-01-01 – 1996-12-31: -5567000 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 57000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLLAGENEX PHARMACEUTICALS INC · 1996-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Free cash flow: -5624000 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5567000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0001015357-99-000043.txt#2333 Input fundies:CapitalExpenditure: 57000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0001015357-99-000043.txt#2337 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 8.62 million Exact value Exact value: -8624000 USD 1997-01-01 – 1997-12-31: -8624000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLLAGENEX PHARMACEUTICALS INC · 1997-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Net Income: -8624000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8624000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0001015357-00-000041.txt#2408 The citation records this snapshot. The page link may show a newer release later.	−USD 6.98 million Exact value Exact value: -6981000 USD 1997-01-01 – 1997-12-31: -6981000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLLAGENEX PHARMACEUTICALS INC · 1997-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Operating Cash Flow: -6981000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6981000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0001015357-00-000041.txt#2420 The citation records this snapshot. The page link may show a newer release later.	USD 78,000 Exact value Exact value: 78000 USD 1997-01-01 – 1997-12-31: 78000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLLAGENEX PHARMACEUTICALS INC · 1997-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Capital Expenditure: 78000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 78000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0001015357-00-000041.txt#2423 The citation records this snapshot. The page link may show a newer release later.	−USD 7.06 million Calculation and evidence -6981000 − 78000 USD Exact free cash flow: -7059000 USD 1997-01-01 – 1997-12-31: -6981000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 78000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLLAGENEX PHARMACEUTICALS INC · 1997-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Free cash flow: -7059000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6981000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0001015357-00-000041.txt#2420 Input fundies:CapitalExpenditure: 78000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0001015357-00-000041.txt#2423 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 11.57 million Exact value Exact value: -11566000 USD 1998-01-01 – 1998-12-31: -11566000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLLAGENEX PHARMACEUTICALS INC · 1998-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Net Income: -11566000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11566000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-01-000047.txt#2981 The citation records this snapshot. The page link may show a newer release later.	−USD 12.31 million Exact value Exact value: -12311000 USD 1998-01-01 – 1998-12-31: -12311000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLLAGENEX PHARMACEUTICALS INC · 1998-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Operating Cash Flow: -12311000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12311000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-01-000047.txt#2996 The citation records this snapshot. The page link may show a newer release later.	USD 230,000 Exact value Exact value: 230000 USD 1998-01-01 – 1998-12-31: 230000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLLAGENEX PHARMACEUTICALS INC · 1998-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Capital Expenditure: 230000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 230000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-01-000047.txt#2999 The citation records this snapshot. The page link may show a newer release later.	−USD 12.54 million Calculation and evidence -12311000 − 230000 USD Exact free cash flow: -12541000 USD 1998-01-01 – 1998-12-31: -12311000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 230000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLLAGENEX PHARMACEUTICALS INC · 1998-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Free cash flow: -12541000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12311000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-01-000047.txt#2996 Input fundies:CapitalExpenditure: 230000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-01-000047.txt#2999 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 14.59 million Exact value Exact value: -14591000 USD 1999-01-01 – 1999-12-31: -14591000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLLAGENEX PHARMACEUTICALS INC · 1999-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Net Income: -14591000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14591000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-01-000047.txt#2981 The citation records this snapshot. The page link may show a newer release later.	−USD 13.97 million Exact value Exact value: -13965000 USD 1999-01-01 – 1999-12-31: -13965000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLLAGENEX PHARMACEUTICALS INC · 1999-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Operating Cash Flow: -13965000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13965000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-01-000047.txt#2996 The citation records this snapshot. The page link may show a newer release later.	USD 593,000 Exact value Exact value: 593000 USD 1999-01-01 – 1999-12-31: 593000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLLAGENEX PHARMACEUTICALS INC · 1999-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Capital Expenditure: 593000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 593000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-01-000047.txt#2999 The citation records this snapshot. The page link may show a newer release later.	−USD 14.56 million Calculation and evidence -13965000 − 593000 USD Exact free cash flow: -14558000 USD 1999-01-01 – 1999-12-31: -13965000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 593000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLLAGENEX PHARMACEUTICALS INC · 1999-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Free cash flow: -14558000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13965000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-01-000047.txt#2996 Input fundies:CapitalExpenditure: 593000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-01-000047.txt#2999 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 8.83 million Exact value Exact value: -8830000 USD 2000-01-01 – 2000-12-31: -8830000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLLAGENEX PHARMACEUTICALS INC · 2000-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Net Income: -8830000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8830000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-01-000047.txt#2981 The citation records this snapshot. The page link may show a newer release later.	−USD 8.77 million Exact value Exact value: -8765000 USD 2000-01-01 – 2000-12-31: -8765000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLLAGENEX PHARMACEUTICALS INC · 2000-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Operating Cash Flow: -8765000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8765000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-01-000047.txt#2996 The citation records this snapshot. The page link may show a newer release later.	USD 169,000 Exact value Exact value: 169000 USD 2000-01-01 – 2000-12-31: 169000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLLAGENEX PHARMACEUTICALS INC · 2000-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Capital Expenditure: 169000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 169000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-01-000047.txt#2999 The citation records this snapshot. The page link may show a newer release later.	−USD 8.93 million Calculation and evidence -8765000 − 169000 USD Exact free cash flow: -8934000 USD 2000-01-01 – 2000-12-31: -8765000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 169000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLLAGENEX PHARMACEUTICALS INC · 2000-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Free cash flow: -8934000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8765000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-01-000047.txt#2996 Input fundies:CapitalExpenditure: 169000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-01-000047.txt#2999 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 8.14 million Exact value Exact value: -8144000 USD 2001-01-01 – 2001-12-31: -8144000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLLAGENEX PHARMACEUTICALS INC · 2001-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Net Income: -8144000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8144000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4348 The citation records this snapshot. The page link may show a newer release later.	−USD 7.88 million Exact value Exact value: -7883000 USD 2001-01-01 – 2001-12-31: -7883000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLLAGENEX PHARMACEUTICALS INC · 2001-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Operating Cash Flow: -7883000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7883000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4362 The citation records this snapshot. The page link may show a newer release later.	USD 131,000 Exact value Exact value: 131000 USD 2001-01-01 – 2001-12-31: 131000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLLAGENEX PHARMACEUTICALS INC · 2001-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Capital Expenditure: 131000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 131000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4365 The citation records this snapshot. The page link may show a newer release later.	−USD 8.01 million Calculation and evidence -7883000 − 131000 USD Exact free cash flow: -8014000 USD 2001-01-01 – 2001-12-31: -7883000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 131000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLLAGENEX PHARMACEUTICALS INC · 2001-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Free cash flow: -8014000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7883000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4362 Input fundies:CapitalExpenditure: 131000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4365 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	USD 902,000 Exact value Exact value: 902000 USD 2002-01-01 – 2002-12-31: 902000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLLAGENEX PHARMACEUTICALS INC · 2002-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Net Income: 902000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: 902000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4348 The citation records this snapshot. The page link may show a newer release later.	USD 3.95 million Exact value Exact value: 3951000 USD 2002-01-01 – 2002-12-31: 3951000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLLAGENEX PHARMACEUTICALS INC · 2002-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Operating Cash Flow: 3951000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3951000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4362 The citation records this snapshot. The page link may show a newer release later.	USD 298,000 Exact value Exact value: 298000 USD 2002-01-01 – 2002-12-31: 298000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLLAGENEX PHARMACEUTICALS INC · 2002-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Capital Expenditure: 298000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 298000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4365 The citation records this snapshot. The page link may show a newer release later.	USD 3.65 million Calculation and evidence 3951000 − 298000 USD Exact free cash flow: 3653000 USD 2002-01-01 – 2002-12-31: 3951000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 298000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLLAGENEX PHARMACEUTICALS INC · 2002-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Free cash flow: 3653000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3951000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4362 Input fundies:CapitalExpenditure: 298000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4365 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	USD 6.43 million Exact value Exact value: 6427000 USD 2003-01-01 – 2003-12-31: 6427000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLLAGENEX PHARMACEUTICALS INC · 2003-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Net Income: 6427000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: 6427000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4348 The citation records this snapshot. The page link may show a newer release later.	USD 4.84 million Exact value Exact value: 4837000 USD 2003-01-01 – 2003-12-31: 4837000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLLAGENEX PHARMACEUTICALS INC · 2003-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Operating Cash Flow: 4837000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4837000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4362 The citation records this snapshot. The page link may show a newer release later.	USD 305,000 Exact value Exact value: 305000 USD 2003-01-01 – 2003-12-31: 305000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLLAGENEX PHARMACEUTICALS INC · 2003-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Capital Expenditure: 305000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 305000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4365 The citation records this snapshot. The page link may show a newer release later.	USD 4.53 million Calculation and evidence 4837000 − 305000 USD Exact free cash flow: 4532000 USD 2003-01-01 – 2003-12-31: 4837000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 305000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLLAGENEX PHARMACEUTICALS INC · 2003-12-31 COLLAGENEX PHARMACEUTICALS INC (edgar:1012270) Free cash flow: 4532000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012270?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4837000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4362 Input fundies:CapitalExpenditure: 305000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012270/0000903100-04-000130.txt#4365 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

51 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001012270, 1012270, edgar:1012270

COLLAGENEX PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2003 2003-01-01 – 2003-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation